Jim Cramer: Pfizer Acting Better Since Broken Allergan Deal
Pfizer walked away from Allergan and the stock has acted better, said TheStreet's Jim Cramer.
Pfizer (PFE) - Get Report walked away from Allergan (AGN) - Get Report and the stock has acted better, said TheStreet's Jim Cramer. He said Allergan will eventually rebound although it is under pressure now.
At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.
